Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Faces Setbacks In Vioxx Suits

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm plans to appeal New Orleans federal court verdict; New Jersey state court nullifies recent win due to NEJM editorial.

You may also be interested in...



Merck To Request New Trial On Liability Following Judge’s Vioxx Decision

New Orleans federal court judge overturns a jury decision awarding $51 mil. in damages in a Vioxx liability suit, calling the amount "excessive."

Merck To Request New Trial On Liability Following Judge’s Vioxx Decision

New Orleans federal court judge overturns a jury decision awarding $51 mil. in damages in a Vioxx liability suit, calling the amount "excessive."

Vioxx Cardiovascular Outcomes Withheld From VIGOR Article, NEJM Says

Additional cardiovascular events from the VIGOR study were known by study authors but not included in the manuscript submission to the New England Journal of Medicine, the journal says.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS064689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel